AstraZeneca at ASCO 2026

By Vladimir Simeonov

AstraZeneca is set to showcase Phase III data in liver, breast, and bladder cancers at the ASCO Annual Meeting.

Ready to turn your data into competitive advantage?

Join pharma commercial teams across Europe using Pharmalyze.AI to move faster, sell smarter, and make decisions that drive measurable results.